Oswald Bentinck
Company: Rocket Pharmaceuticals Ltd.
Job title: Vice President - Head of Value and Access
Seminars:
Strategizing to Gain EMA Regulatory Approval & Aligning Regulatory and Payer Expectations 9:05 am
The European market is a notoriously tricky area to navigate for gene therapy products, and there is a significant disconnect between what regulators require for a product to gain approval, and what payers require from a product. This workshop will provide a discussion-based deep-dive into the best strategies to build adequately robust data packages for…Read more
day: Pre-Conference Workshop Day